Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice

Yuda Zong, Xinghe Wang, K. Craig Goodrich, Aaron M. Mohs, Dennis L. Parker, Zheng Rong Lu

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The structures of polydisulfide-based biodegradable macromolecular Gd(III) complexes were modified to improve their in vivo retention time and MRI contrast enhancement. Steric hindrance was introduced around the disulfide bonds to control their access to free thiols in order to alter the degradation rate of the copolymers. Two new macromolecular agents, (Gd-DTPA)-cystine copolymers (GDCP) and (Gd-DTPA)-cystine diethyl ester copolymers (GDCEP), were prepared. Both agents were readily degraded in vitro and in vivo by the disulfide-thiol exchange reaction, but at a slow rate. The introduction of COOH and COOEt groups slowed down the degradation of the copolymers in the incubation with 15 μM cysteine. Metabolic degradation products were identified by matrix-assisted laser desorption/ ionization time-of-flight (MALDI-TOF) mass spectrometry in the urine samples from rats injected with the agents. The T1 relaxivity (r1) was 5.43 mM-1s-1 for GDCP, and 5.86 mM-1s-1 for GDCEP, respectively, at 3T. MRI contrast enhancement of both agents was studied in nude mice bearing MDA-BM-231 human breast carcinoma xenografts, on a Siemens Trio 3T scanner. The modified agents resulted in more significant contrast enhancement in the blood pool and tumor periphery than (Gd-DTPA)-cystamine copolymers (GDCC) and a low-molecular-weight control agent, Gd-(DTPA-BMA), at a dose of 0.1 mmol-Gd/kg. The results demonstrate that the structural modification of the biodegradable macromolecular Gd(III) complexes resulted in a relatively slow degradation of the macromolecules and significantly improved in vivo contrast enhancement. The modified agents show promise for use in investigations of blood pool and cancer by contrast-enhanced (CE) MRI.

Original languageEnglish (US)
Pages (from-to)835-842
Number of pages8
JournalMagnetic Resonance in Medicine
Volume53
Issue number4
DOIs
StatePublished - Apr 1 2005

Fingerprint

gadodiamide
Sulfhydryl Compounds
Disulfides
Cystamine
Gadolinium DTPA
Heterografts
Nude Mice
Cysteine
Mass Spectrometry
Neoplasms
Lasers
Molecular Weight
Urine
Breast Neoplasms
gadolinium-DTPA cystine diethyl ester copolymer
gadolinium-DTPA cystine copolymer
DTPA copolymer
In Vitro Techniques

Keywords

  • Biodegradation
  • Contrast agents
  • Macromolecular Gd(III) complexes
  • Polydisulfide
  • Tumor MRI

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice. / Zong, Yuda; Wang, Xinghe; Goodrich, K. Craig; Mohs, Aaron M.; Parker, Dennis L.; Lu, Zheng Rong.

In: Magnetic Resonance in Medicine, Vol. 53, No. 4, 01.04.2005, p. 835-842.

Research output: Contribution to journalArticle

Zong, Yuda ; Wang, Xinghe ; Goodrich, K. Craig ; Mohs, Aaron M. ; Parker, Dennis L. ; Lu, Zheng Rong. / Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice. In: Magnetic Resonance in Medicine. 2005 ; Vol. 53, No. 4. pp. 835-842.
@article{eb27328b2d2a425f89718b58a026f40e,
title = "Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice",
abstract = "The structures of polydisulfide-based biodegradable macromolecular Gd(III) complexes were modified to improve their in vivo retention time and MRI contrast enhancement. Steric hindrance was introduced around the disulfide bonds to control their access to free thiols in order to alter the degradation rate of the copolymers. Two new macromolecular agents, (Gd-DTPA)-cystine copolymers (GDCP) and (Gd-DTPA)-cystine diethyl ester copolymers (GDCEP), were prepared. Both agents were readily degraded in vitro and in vivo by the disulfide-thiol exchange reaction, but at a slow rate. The introduction of COOH and COOEt groups slowed down the degradation of the copolymers in the incubation with 15 μM cysteine. Metabolic degradation products were identified by matrix-assisted laser desorption/ ionization time-of-flight (MALDI-TOF) mass spectrometry in the urine samples from rats injected with the agents. The T1 relaxivity (r1) was 5.43 mM-1s-1 for GDCP, and 5.86 mM-1s-1 for GDCEP, respectively, at 3T. MRI contrast enhancement of both agents was studied in nude mice bearing MDA-BM-231 human breast carcinoma xenografts, on a Siemens Trio 3T scanner. The modified agents resulted in more significant contrast enhancement in the blood pool and tumor periphery than (Gd-DTPA)-cystamine copolymers (GDCC) and a low-molecular-weight control agent, Gd-(DTPA-BMA), at a dose of 0.1 mmol-Gd/kg. The results demonstrate that the structural modification of the biodegradable macromolecular Gd(III) complexes resulted in a relatively slow degradation of the macromolecules and significantly improved in vivo contrast enhancement. The modified agents show promise for use in investigations of blood pool and cancer by contrast-enhanced (CE) MRI.",
keywords = "Biodegradation, Contrast agents, Macromolecular Gd(III) complexes, Polydisulfide, Tumor MRI",
author = "Yuda Zong and Xinghe Wang and Goodrich, {K. Craig} and Mohs, {Aaron M.} and Parker, {Dennis L.} and Lu, {Zheng Rong}",
year = "2005",
month = "4",
day = "1",
doi = "10.1002/mrm.20402",
language = "English (US)",
volume = "53",
pages = "835--842",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice

AU - Zong, Yuda

AU - Wang, Xinghe

AU - Goodrich, K. Craig

AU - Mohs, Aaron M.

AU - Parker, Dennis L.

AU - Lu, Zheng Rong

PY - 2005/4/1

Y1 - 2005/4/1

N2 - The structures of polydisulfide-based biodegradable macromolecular Gd(III) complexes were modified to improve their in vivo retention time and MRI contrast enhancement. Steric hindrance was introduced around the disulfide bonds to control their access to free thiols in order to alter the degradation rate of the copolymers. Two new macromolecular agents, (Gd-DTPA)-cystine copolymers (GDCP) and (Gd-DTPA)-cystine diethyl ester copolymers (GDCEP), were prepared. Both agents were readily degraded in vitro and in vivo by the disulfide-thiol exchange reaction, but at a slow rate. The introduction of COOH and COOEt groups slowed down the degradation of the copolymers in the incubation with 15 μM cysteine. Metabolic degradation products were identified by matrix-assisted laser desorption/ ionization time-of-flight (MALDI-TOF) mass spectrometry in the urine samples from rats injected with the agents. The T1 relaxivity (r1) was 5.43 mM-1s-1 for GDCP, and 5.86 mM-1s-1 for GDCEP, respectively, at 3T. MRI contrast enhancement of both agents was studied in nude mice bearing MDA-BM-231 human breast carcinoma xenografts, on a Siemens Trio 3T scanner. The modified agents resulted in more significant contrast enhancement in the blood pool and tumor periphery than (Gd-DTPA)-cystamine copolymers (GDCC) and a low-molecular-weight control agent, Gd-(DTPA-BMA), at a dose of 0.1 mmol-Gd/kg. The results demonstrate that the structural modification of the biodegradable macromolecular Gd(III) complexes resulted in a relatively slow degradation of the macromolecules and significantly improved in vivo contrast enhancement. The modified agents show promise for use in investigations of blood pool and cancer by contrast-enhanced (CE) MRI.

AB - The structures of polydisulfide-based biodegradable macromolecular Gd(III) complexes were modified to improve their in vivo retention time and MRI contrast enhancement. Steric hindrance was introduced around the disulfide bonds to control their access to free thiols in order to alter the degradation rate of the copolymers. Two new macromolecular agents, (Gd-DTPA)-cystine copolymers (GDCP) and (Gd-DTPA)-cystine diethyl ester copolymers (GDCEP), were prepared. Both agents were readily degraded in vitro and in vivo by the disulfide-thiol exchange reaction, but at a slow rate. The introduction of COOH and COOEt groups slowed down the degradation of the copolymers in the incubation with 15 μM cysteine. Metabolic degradation products were identified by matrix-assisted laser desorption/ ionization time-of-flight (MALDI-TOF) mass spectrometry in the urine samples from rats injected with the agents. The T1 relaxivity (r1) was 5.43 mM-1s-1 for GDCP, and 5.86 mM-1s-1 for GDCEP, respectively, at 3T. MRI contrast enhancement of both agents was studied in nude mice bearing MDA-BM-231 human breast carcinoma xenografts, on a Siemens Trio 3T scanner. The modified agents resulted in more significant contrast enhancement in the blood pool and tumor periphery than (Gd-DTPA)-cystamine copolymers (GDCC) and a low-molecular-weight control agent, Gd-(DTPA-BMA), at a dose of 0.1 mmol-Gd/kg. The results demonstrate that the structural modification of the biodegradable macromolecular Gd(III) complexes resulted in a relatively slow degradation of the macromolecules and significantly improved in vivo contrast enhancement. The modified agents show promise for use in investigations of blood pool and cancer by contrast-enhanced (CE) MRI.

KW - Biodegradation

KW - Contrast agents

KW - Macromolecular Gd(III) complexes

KW - Polydisulfide

KW - Tumor MRI

UR - http://www.scopus.com/inward/record.url?scp=16444371935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16444371935&partnerID=8YFLogxK

U2 - 10.1002/mrm.20402

DO - 10.1002/mrm.20402

M3 - Article

C2 - 15799038

AN - SCOPUS:16444371935

VL - 53

SP - 835

EP - 842

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 4

ER -